MIM
AZN icon

Merrion Investment Management’s AstraZeneca AZN Stock Holding History

Merrion Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-528
Closed -$53K – 94
2020
Q4 		$53K Buy
+528
New +$55.9K 0.04% 122

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Merrion Investment Management's AZN Position: Q1 2021 in Review

Merrion Investment Management sold out of AstraZeneca (AZN) in Q1 2021, closing a stake of 528 shares — an estimated $53K sold.

Merrion Investment Management first reported a position in AZN in Q4 2020 and held it in 1 quarter. The position peaked at $53K in Q4 2020. 756 funds tracked by Wall St. Rank hold AZN as of Q1 2021.

  • Merrion Investment Management reported no remaining AstraZeneca position as of Q1 2021 after selling out during the quarter.
  • Merrion Investment Management sold 528 AstraZeneca shares in Q1 2021, an estimated $53K.
  • Merrion Investment Management first reported a position in AstraZeneca in Q4 2020 and held it in 1 quarter.
  • Merrion Investment Management's AstraZeneca position peaked at $53K in Q4 2020.
  • 756 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2021.

Based on Merrion Investment Management's 13F filing for Q1 2021, filed 29 Apr 2021.